NEW YORK (TheStreet) -- Shares of Agilent Technologies (A) are gaining 0.96% to $39.87 after the company introduced a new module that shortens injection cycles, lowers carryover and enlarges sample capacity.
Agilent Technologies is an electronics company that designs and manufactures measurement instruments and equipment for life sciences, medical diagnostics and chemistry applications.
The new sampler, 1290 Infinity II Vialsampler, is being shown for the first time in Geneva at an international symposium on high-performance liquid phase separations and related techniques, the company said.
"With this new offering, labs can more easily move from HPLC to UHPLC methods for higher resolution and faster separations," Agilent VP Dr. Stefan Schuette noted.
He added that the new module combines auto-sampler features with options to integrate both a column oven and a sample cooler, giving laboratories a cost-effective way to experience the advantages of ultra-high-pressure liquid chromatography.
Separately, TheStreet Ratings team rates AGILENT TECHNOLOGIES INC as a Buy with a ratings score of B. TheStreet Ratings Team has this to say about their recommendation:
"We rate AGILENT TECHNOLOGIES INC (A) a BUY. This is driven by a few notable strengths, which we believe should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks we cover. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels, growth in earnings per share and expanding profit margins. We feel its strengths outweigh the fact that the company has had sub par growth in net income."